Where does iQure Pharma's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across iQure Pharma's 4 recorded funding rounds.

Premier Alternatives

iQure Pharma

Princeton, NJ · Founded 2019 · Privately Held (backing)

Developer of biopharmaceutical therapies designed to address central nervous system disorders by restoring glutamate homeostasis. iQure Pharma is based in Princeton, NJ and was founded in 2019. Its last reported valuation was $21 million in Nov 2025. It has raised $13.1 million across 4 recorded rounds; the latest was a $650,000 seed round in May 2026.

Last reported valuation

$21.0M

Oct 2026

Priced at

—

Total raised

$13.1M

Last round

Seed Round

May 2026

Cap table — not yet on record

iQure Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of iQure Pharma with a free account

·Watch iQure Pharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about iQure Pharma

Where does iQure Pharma's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across iQure Pharma's 4 recorded funding rounds.